Literature DB >> 23769489

Comparison of systolic and diastolic criteria for isolated LV noncompaction in CMR.

R Brandon Stacey1, Mousumi M Andersen, Mitchell St Clair, W Gregory Hundley, Vinay Thohan.   

Abstract

OBJECTIVES: This study used cardiac magnetic resonance (CMR) to compare standard criteria for left ventricular noncompaction (LVNC).
BACKGROUND: LVNC as a distinct cardiomyopathy is supported by a growing number of publications. Echocardiographic and CMR criteria have been established to diagnosis LVNC but have led to concerns of diagnostic accuracy.
METHODS: Trabeculation/possible LVNC by CMR was retrospectively observed in 122 consecutive cases. We compared the standard end-systolic noncompacted-to-compacted ratio (ESNCCR), end-diastolic noncompacted:compacted ratio (EDNCCR), and trabecular mass-to-total mass ratio (TMTMR) along with deaths, embolic events, congestive heart failure (CHF) readmissions, ventricular arrhythmias, myocardial thickening (MT), left ventricular ejection fraction (LVEF), 3-dimensional sphericity index (3DSi), and left ventricular end-diastolic volume index. Adjusting for age, race, sex, body surface area, diabetes mellitus, hypertension, hyperlipidemia, coronary artery disease, and CHF, logistic regression was used to compare combined events (death, CHF readmission, embolism, ventricular arrhythmia) between ESNCCR, EDNCCR, and TMTMR. Adjusting for same covariates except CHF, logistic regression was used to compare the odds of CHF for those who met criteria and those who did not. Using analysis of covariance, adjusted means for LVEF, MT, 3DSi, and left ventricular end-diastolic volume index were generated.
RESULTS: ES criteria had a higher odds ratio (8.6; 95% confidence interval [CI]: 2.5 to 33) for combined events than ED criteria (1.8; 95% CI: 0.6 to 5.8) or TMTMR criteria (3.14; 95% CI: 1.09 to 10.2). The odds ratio of CHF for those who met ESNCCR criteria was 29.4 (95% CI: 6.6 to 125), but the odds ratio of CHF for those who met EDNCCR criteria was 3.3 (95% CI: 1.1 to 9.2). After adjustment, those who met criteria for noncompaction by ESNCCR had a lower LVEF and less MT than those who did not (p = 0.01 and p = 0.003, respectively), but there was no difference between those who met criteria for EDNCCR or the TMTMR criteria and those who did not.
CONCLUSIONS: ES measures of LVNC have stronger associations with events, CHF, and systolic dysfunction than other measures.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  3-dimensional sphericity index; 3DSi; BSA; CHF; CMR; ED; EDNCCR; ES; ESNCCR; LV; LVEDVi; LVEF; LVNC; MT; NC; TMTMR; body surface area; cardiac magnetic resonance; cardiomyopathy; congestive heart failure; end-diastolic; end-diastolic noncompacted-to-compacted ratio; end-systolic; end-systolic noncompacted-to-compacted ratio; left ventricular; left ventricular ejection fraction; left ventricular end-diastolic volume index; left ventricular noncompaction; myocardial thickening; noncompaction; trabecular mass-to-total mass ratio

Mesh:

Year:  2013        PMID: 23769489     DOI: 10.1016/j.jcmg.2013.01.014

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  30 in total

1.  Improvement in systolic function in left ventricular non-compaction cardiomyopathy: A case report.

Authors:  Tiffany Lin; Michael Wesley Milks; Bharathi Upadhya; William Gregory Hundley; Richard Brandon Stacey
Journal:  J Cardiol Cases       Date:  2014-09-06

Review 2.  Evaluation and management of left ventricular noncompaction cardiomyopathy.

Authors:  R Brandon Stacey; Augustus J Caine; W Gregory Hundley
Journal:  Curr Heart Fail Rep       Date:  2015-02

Review 3.  Cardiac magnetic resonance imaging in heart failure: where the alphabet begins!

Authors:  Ahmed Aljizeeri; Abdulbaset Sulaiman; Naji Alhulaimi; Ahmed Alsaileek; Mouaz H Al-Mallah
Journal:  Heart Fail Rev       Date:  2017-07       Impact factor: 4.214

Review 4.  Athlete's Heart: Diagnostic Challenges and Future Perspectives.

Authors:  Carlo De Innocentiis; Fabrizio Ricci; Mohammed Y Khanji; Nay Aung; Claudio Tana; Elvira Verrengia; Steffen E Petersen; Sabina Gallina
Journal:  Sports Med       Date:  2018-11       Impact factor: 11.136

5.  Role of Cardiac MR Imaging in Cardiomyopathies.

Authors:  Christopher M Kramer
Journal:  J Nucl Med       Date:  2015-06       Impact factor: 10.057

Review 6.  Non-compaction cardiomyopathy: prevalence, prognosis, pathoetiology, genetics, and risk of cardioembolism.

Authors:  Pedro Carrilho-Ferreira; Ana G Almeida; Fausto J Pinto
Journal:  Curr Heart Fail Rep       Date:  2014-12

Review 7.  Impact of cardiac magnetic resonance imaging in non-ischemic cardiomyopathies.

Authors:  Kevin Kalisz; Prabhakar Rajiah
Journal:  World J Cardiol       Date:  2016-02-26

Review 8.  Left ventricular noncompaction, morphological, and clinical features for an integrated diagnosis.

Authors:  Francesco Negri; Antonio De Luca; Enrico Fabris; Renata Korcova; Carlo Cernetti; Chrysanthos Grigoratos; Giovanni Donato Aquaro; Gaetano Nucifora; Paolo G Camici; Gianfranco Sinagra
Journal:  Heart Fail Rev       Date:  2019-05       Impact factor: 4.214

9.  Right ventricular morphology and systolic function in left ventricular noncompaction cardiomyopathy.

Authors:  Richard Brandon Stacey; Mousumi Andersen; Jason Haag; Michael E Hall; George McLeod; Bharathi Upadhya; William Gregory Hundley; Vinay Thohan
Journal:  Am J Cardiol       Date:  2013-12-25       Impact factor: 2.778

10.  The Role of Cardiovascular Magnetic Resonance (CMR) and Computed Tomography (CCT) in Facilitating Heart Failure Management.

Authors:  R Brandon Stacey; W Gregory Hundley
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.